RECRUITING

Positive Peers Intervention Clinical Trial

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to learn if the Positive Peers mobile app intervention increases rates of viral suppression in young (13-34 y/o) persons with HIV. Does use of the Positive Peers app improve viral suppression among young minority persons with HIV? What user characteristics are associated with a) viral suppression, b) retention in care, and c) perceived HIV-related stigma? Participants will: * download the mobile app onto their personal smartphone * Use the mobile app as they find useful * complete online surveys at enrollment, 3 mo, 6, mo, 9 mo and 12 months.

Official Title

Randomized Control Trial of Positive Peers MHealth App As a Clinic-based Intervention to Optimize HIV Outcomes Among Young, Minority Persons Living with HIV

Quick Facts

Study Start:2024-06-03
Study Completion:2027-11
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06388109

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:13 Years to 34 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * HIV+
  2. * Identifies as either a racial, ethnic, sexual or gender minority
  3. * Newly diagnosed within last 12 months
  4. * Out of care (greater than 6 months between any two HIV provider visits in last 24 months)
  5. * Not virally suppressed (any viral load \> 200 copies in last 24 months)
  6. * Has a working smartphone
  7. * Functional English ability
  1. * prior use of Positive Peers mobile app

Contacts and Locations

Study Contact

Jennifer McMillen-Smith, LISW-S
CONTACT
2167784051
jmsmith@metrohealth.org
Ann Avery, MD
CONTACT
aavery@metrohealth.org

Principal Investigator

Ann Avery, MD
PRINCIPAL_INVESTIGATOR
MetroHealth/ CWRU
Mary Step, PhD
PRINCIPAL_INVESTIGATOR
Kent State University

Study Locations (Sites)

Northeast Valley Health Corporation
Van Nuys, California, 91405
United States
Infectious Disease Practice- Rutgers University
Newark, New Jersey, 07103
United States
Equitas Health
Cincinnati, Ohio, 45206
United States
Equitas Health
Columbus, Ohio, 43203
United States
Thomas Street Clinic
Houston, Texas, 77004-8004
United States
UW Madison Clinic at Harborview
Seattle, Washington, 98104
United States

Collaborators and Investigators

Sponsor: MetroHealth Medical Center

  • Ann Avery, MD, PRINCIPAL_INVESTIGATOR, MetroHealth/ CWRU
  • Mary Step, PhD, PRINCIPAL_INVESTIGATOR, Kent State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-06-03
Study Completion Date2027-11

Study Record Updates

Study Start Date2024-06-03
Study Completion Date2027-11

Terms related to this study

Additional Relevant MeSH Terms

  • HIV Infections